Etanercept treatment for children and adolescents with plaque psoriasis by Paller Amy S, Siegfried Elaine C, Langley Richard G, Gottlieb Alice B, Pariser David, Landells Ian, Hebert Adelaide A, Eichenfield Lawrence F, Patel Vaishali, Creamer Kara, Jahreis Angelika, Etanercept Pediatric Psoriasis Study Group in The New England journal of medicine (2008).

[PMID: 18199863] PubMed


Etanercept, a soluble tumor necrosis factor receptor, has been shown to lessen disease severity in adult patients with psoriasis. We assessed the efficacy and safety of etanercept in children and adolescents with moderate-to-severe plaque psoriasis.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.